DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Zinner RG, Obasaju CK, Spigel DR. et al.
PRONOUNCE: randomized, open-label, phase III study of first-line pemetrexed + carboplatin followed by maintenance pemetrexed versus paclitaxel + carboplatin + bevacizumab followed by maintenance bevacizumab in patients ith advanced nonsquamous non-small-cell lung cancer.
J Thorac Oncol 2015;
10 (01) 134-142
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.